ScoreWhy is Procter & Gamble Health Ltd ?
1
High Management Efficiency with a high ROE of 41.55%
2
The company is Net-Debt Free
3
Poor long term growth as Net Sales has grown by an annual rate of 7.27% and Operating profit at 15.39% over the last 5 years
4
Flat results in Jun 26
5
With ROE of 64.1, it has a Very Expensive valuation with a 18.1 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -9.81%, its profits have risen by 10.9% ; the PEG ratio of the company is 2.6
- At the current price, the company has a high dividend yield of 3.6
6
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -1.1% over the previous quarter and collectively hold 18.77% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
7
Below par performance in long term as well as near term
- Along with generating -9.81% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to P & G Health Ltd should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is P & G Health Ltd for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
P & G Health Ltd
-9.81%
-0.40
24.35%
Sensex
-3.52%
-0.26
13.43%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.27%
EBIT Growth (5y)
15.39%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.36
Sales to Capital Employed (avg)
1.80
Tax Ratio
27.19%
Dividend Payout Ratio
88.52%
Pledged Shares
0
Institutional Holding
18.77%
ROCE (avg)
87.52%
ROE (avg)
41.55%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
28
Industry P/E
37
Price to Book Value
18.11
EV to EBIT
20.88
EV to EBITDA
19.80
EV to Capital Employed
27.61
EV to Sales
6.44
PEG Ratio
2.60
Dividend Yield
3.62%
ROCE (Latest)
117.46%
ROE (Latest)
64.14%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
PAT(Latest six months)
At Rs 167.07 cr has Grown at 31.18%
EPS(Q)
Highest at Rs 57.92
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for P & G Health Ltd
Profit After Tax (PAT) - Latest six months
At Rs 167.07 cr has Grown at 31.18%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 57.92
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
